☰

Jan Booij, Ph.D, M.D. - Publications

Affiliations: 
Academic Medical Center Amsterdam, Amsterdam, Netherlands 
Area:
nucleair medicine neuropsychiatrics
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

229 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Koster M, van der Pluijm M, van de Giessen E, Schrantee A, van Hooijdonk CFM, Selten JP, Booij J, de Haan L, Ziermans T, Vermeulen J. The association of tobacco smoking and metabolite levels in the anterior cingulate cortex of first-episode psychosis patients: A case-control and 6-month follow-up H-MRS study. Schizophrenia Research. 271: 144-152. PMID 39029144 DOI: 10.1016/j.schres.2024.07.022  0.552
2024 van Hooijdonk CFM, Balvers MGJ, van der Pluijm M, Smith CLC, de Haan L, Schrantee A, Yaqub M, Witkamp RF, van de Giessen E, van Amelsvoort TAMJ, Booij J, Selten JP. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals. Psychological Medicine. 1-11. PMID 38389452 DOI: 10.1017/S0033291724000291  0.597
2024 van der Pluijm M, Alting M, Schrantee A, Edden RAE, Booij J, de Haan L, van de Giessen E. Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients. Schizophrenia Research. 264: 471-478. PMID 38277736 DOI: 10.1016/j.schres.2024.01.025  0.557
2023 Boucherie DE, Reneman L, Booij J, Martins D, Dipasquale O, Schrantee A. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study. Journal of Psychopharmacology (Oxford, England). 2698811231211154. PMID 37947344 DOI: 10.1177/02698811231211154  0.709
2023 van Galen KA, Schrantee A, Ter Horst KW, la Fleur SE, Booij J, Constable RT, Schwartz GJ, DiLeone RJ, Serlie MJ. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study. Nature Metabolism. PMID 37308722 DOI: 10.1038/s42255-023-00816-9  0.58
2021 Schalbroeck R, de Geus-Oei LF, Selten JP, Yaqub M, Schrantee A, van Amelsvoort T, Booij J, van Velden FHP. Cerebral [F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits. Diagnostics (Basel, Switzerland). 11. PMID 34943640 DOI: 10.3390/diagnostics11122404  0.598
2021 van Galen KA, Booij J, Schrantee A, Adriaanse SM, Unmehopa UA, Fliers E, Schwartz GJ, DiLeone RJ, Ter Horst KW, la Fleur SE, Serlie MJ. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity. Metabolism: Clinical and Experimental. 154839. PMID 34331964 DOI: 10.1016/j.metabol.2021.154839  0.605
2020 Hartstra AV, Schüppel V, Imangaliyev S, Schrantee A, Prodan A, Collard D, Levin E, Dallinga-Thie G, Ackermans MT, Winkelmeijer M, Havik SR, Metwaly A, Lagkouvardos I, Nier A, Bergheim I, ... ... Booij J, et al. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Molecular Metabolism. 101076. PMID 32916306 DOI: 10.1016/J.Molmet.2020.101076  0.587
2020 Suwijn SR, Samim H, Eggers C, Espay AJ, Fox S, Lang AE, Samuel M, Silverdale M, Verschuur CVM, Dijk JM, Verberne HJ, Booij J, de Bie RMA. Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD). Journal of Parkinson's Disease. PMID 32597819 DOI: 10.3233/Jpd-202090  0.342
2020 van Deursen DN, van den Heuvel OA, Booij J, Berendse HW, Vriend C. Autonomic failure in Parkinson's disease is associated with striatal dopamine deficiencies. Journal of Neurology. PMID 32162062 DOI: 10.1007/S00415-020-09785-5  0.351
2019 van der Zande JJ, Joling M, Happach IG, Vriend C, Scheltens P, Booij J, Lemstra AW. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An I-FP-CIT SPECT study. Neuroimage. Clinical. 25: 102062. PMID 31790878 DOI: 10.1016/J.Nicl.2019.102062  0.32
2019 Suwijn SR, Verschuur CVM, Slim MA, Booij J, de Bie RMA. Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease. Ejnmmi Research. 9: 63. PMID 31342202 DOI: 10.1186/S13550-019-0537-2  0.348
2019 Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Research. Neuroimaging. 290: 5-13. PMID 31252222 DOI: 10.1016/J.Pscychresns.2019.06.005  0.724
2019 van Duin EDA, Ceccarini J, Booij J, Kasanova Z, Vingerhoets C, van Huijstee J, Heinzel A, Mohammadkhani-Shali S, Winz O, Mottaghy F, Myin-Germeys I, van Amelsvoort T. Lower [18F]fallypride binding to dopamine D2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study. Psychological Medicine. 1-9. PMID 30935427 DOI: 10.1017/S003329171900062X  0.369
2019 Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Journal of Psychopharmacology (Oxford, England). 269881119836229. PMID 30887865 DOI: 10.1177/0269881119836229  0.723
2019 Joling M, Vriend C, Raijmakers PGHM, van der Zande JJ, Lemstra AW, Berendse HW, Booij J, van den Heuvel OA. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An I-FP-CIT SPECT study. Neuroimage. Clinical. 22: 101755. PMID 30884365 DOI: 10.1016/J.Nicl.2019.101755  0.325
2019 Boot E, Hollak CEM, Huijbregts SCJ, Jahja R, van Vliet D, Nederveen AJ, Nieman DH, Bosch AM, Bour LJ, Bakermans AJ, Abeling NGGM, Bassett AS, van Amelsvoort TAMJ, van Spronsen FJ, Booij J. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria. Psychological Medicine. 47: 2854-2865. PMID 28552082 DOI: 10.1017/S0033291717001398  0.329
2018 Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, Heinzel A, Mottaghy FM, Myin-Germeys I. Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 1314-1324. PMID 30482598 DOI: 10.1016/J.Euroneuro.2018.10.002  0.31
2018 Shalgunov V, van Waarde A, Booij J, Michel MC, Dierckx RAJO, Elsinga PH. Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging. Medicinal Research Reviews. PMID 30450619 DOI: 10.1002/Med.21552  0.34
2018 Adriaanse SM, de Wit TC, Stam M, Verwer E, de Bruin KM, Booij J. Clinical evaluation of [I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison. Ejnmmi Research. 8: 85. PMID 30136081 DOI: 10.1186/S13550-018-0436-Y  0.388
2018 Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/J.Euroneuro.2018.07.099  0.738
2018 Joling M, Vriend C, van der Zande JJ, Lemstra AW, van den Heuvel OA, Booij J, Berendse HW. Lower I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies. Neuroimage. Clinical. 19: 130-136. PMID 30035010 DOI: 10.1016/J.Nicl.2018.04.009  0.372
2018 Ter Horst KW, Lammers NM, Trinko R, Opland DM, Figee M, Ackermans MT, Booij J, van den Munckhof P, Schuurman PR, Fliers E, Denys D, DiLeone RJ, la Fleur SE, Serlie MJ. Striatal dopamine regulates systemic glucose metabolism in humans and mice. Science Translational Medicine. 10. PMID 29794060 DOI: 10.1126/Scitranslmed.Aar3752  0.329
2018 van Duin EDA, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MCH, Booij J, Myin-Germeys I, van Amelsvoort T. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29703646 DOI: 10.1016/J.Euroneuro.2018.03.005  0.345
2018 Smit M, Vállez García D, de Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA. Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [C]DASB Positron Emission Tomography Study. Frontiers in Neurology. 9: 88. PMID 29541052 DOI: 10.3389/Fneur.2018.00088  0.344
2018 Stam MK, Verwer EE, Booij J, Adriaanse SM, de Bruin CM, de Wit TC. Performance evaluation of a novel brain-dedicated SPECT system. Ejnmmi Physics. 5: 4. PMID 29492787 DOI: 10.1186/S40658-018-0203-1  0.33
2018 Vingerhoets C, Bakker G, Pluijm Mvd, Bloemen O, Reneman L, Caan M, Booij J, Amelsvoort Tv. S172. BRAIN METABOLITES AND THE RELATION WITH COGNITION AND PSYCHOTIC SYMPTOMS IN MEDICATION-FREE PSYCHOSIS AND CONTROLS: A PHARMACOLOGICAL MAGNETIC RESONANCE SPECTROSCOPY STUDY Schizophrenia Bulletin. 44: S391-S392. DOI: 10.1016/J.Biopsych.2018.02.833  0.549
2018 Schrantee A, Lucassen PJ, Reneman L, Booij J. T138. Serotonin Transporter Occupancy Predicts Default-Mode Network Connectivity: A SPECT and Resting-State fMRI Study Biological Psychiatry. 83: S182. DOI: 10.1016/J.Biopsych.2018.02.475  0.696
2017 Vingerhoets C, Bloemen OJN, Boot E, Bakker G, de Koning MB, da Silva Alves F, Booij J, van Amelsvoort TAMJ. Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis. Psychiatry Research. PMID 29174435 DOI: 10.1016/J.Pscychresns.2017.11.014  0.357
2017 Zoons E, Booij J, Speelman JD, Dreissen YEM, Smit M, Tijssen MAJ. Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms. Ejnmmi Research. 7: 87. PMID 29071431 DOI: 10.1186/S13550-017-0338-4  0.307
2017 van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metabolism: Clinical and Experimental. PMID 28970033 DOI: 10.1016/J.Metabol.2017.09.007  0.306
2017 Joling M, van den Heuvel OA, Berendse HW, Booij J, Vriend C. Serotonin transporter binding and anxiety symptoms in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28899958 DOI: 10.1136/Jnnp-2017-316193  0.407
2017 Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, ... ... Booij J, et al. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28734065 DOI: 10.1002/Mds.27094  0.329
2017 Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/Fj.201601234R  0.736
2017 Kasanova Z, Ceccarini J, Frank MJ, Amelsvoort TV, Booij J, Heinzel A, Mottaghy F, Myin-Germeys I. Striatal dopaminergic modulation of reinforcement learning predicts reward-Oriented behavior in daily life. Biological Psychology. PMID 28461214 DOI: 10.1016/J.Biopsycho.2017.04.014  0.341
2017 Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/Jce.13235  0.699
2017 Zoons E, Tijssen MAJ, Dreissen YEM, Speelman JD, Smit M, Booij J. The relationship between the dopaminergic system and depressive symptoms in cervical dystonia. European Journal of Nuclear Medicine and Molecular Imaging. 44: 1375-1382. PMID 28314910 DOI: 10.1007/S00259-017-3664-X  0.328
2017 Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, ... Booij J, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/Journal.Pone.0172776  0.749
2017 Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, Jonsson C, de Nijs R, Hesse S, Koulibaly PM, Akdemir UO, Koole M, Tatsch K, Varrone A. [(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. Ejnmmi Physics. 4: 8. PMID 28130765 DOI: 10.1186/S40658-017-0175-6  0.316
2017 Selten JP, Booij J, Buwalda B, Meyer-Lindenberg A. Biological Mechanisms Whereby Social Exclusion May Contribute to the Etiology of Psychosis: A Narrative Review. Schizophrenia Bulletin. PMID 28053019 DOI: 10.1093/Schbul/Sbw180  0.351
2017 Schrantee A, Lucassen P, Booij J, Reneman L. Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopram European Neuropsychopharmacology. 27: S707-S708. DOI: 10.1016/S0924-977X(17)31308-1  0.707
2017 Duin EDAv, Kasanova Z, Ceccarini J, Hernaus D, Heinzel A, Mottaghy F, Booij J, Myin-Germeys I, Amelsvoort Tv. 626. Reward Learning and Dopamine Release in Adults with 22q11DS: A Study Using [18F]fallypride Positron Emission Tomography Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.496  0.301
2016 Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP. Reactivity to social stress in ethnic minority men. Psychiatry Research. PMID 27884461 DOI: 10.1016/J.Psychres.2016.10.076  0.411
2016 Joling M, Vriend C, Van den Heuvel OA, Raijmakers PG, Jones PA, Berendse HW, Booij J. Analysis of extrastriatal 123I-FP-CIT binding contributes to the differential diagnosis of parkinsonian diseases. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27856628 DOI: 10.2967/Jnumed.116.182139  0.372
2016 Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W. Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands. Substance Use & Misuse. 1-7. PMID 27613150 DOI: 10.1080/10826084.2016.1201117  0.423
2016 Vegting Y, Reneman L, Booij J. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology. PMID 27568200 DOI: 10.1007/S00213-016-4396-5  0.58
2016 van der Zwaal EM, de Weijer BA, van de Giessen EM, Janssen I, Berends FJ, van de Laar A, Ackermans MT, Fliers E, la Fleur SE, Booij J, Serlie MJ. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27184782 DOI: 10.1016/J.Euroneuro.2016.04.009  0.304
2016 Koopman KE, Roefs A, Elbers DC, Fliers E, Booij J, Serlie MJ, la Fleur SE. Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men. Psychological Medicine. 46: 1707-17. PMID 26984412 DOI: 10.1017/S0033291716000222  0.394
2016 van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1060-6. PMID 26830298 DOI: 10.1007/S00259-016-3312-X  0.352
2016 Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Atay Kapucu LÖ, Svarer C, Koulibaly PM, Nobili F, Pagani M, Sabri O, Sera T, et al. Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26816194 DOI: 10.1007/S00259-016-3309-5  0.371
2015 Vulink NC, Planting RS, Figee M, Booij J, Denys D. Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26711686 DOI: 10.1016/J.Euroneuro.2015.11.018  0.4
2015 de Kwaasteniet BP, Pinto C, Ruhé HG, van Wingen GA, Booij J, Denys D. Correction: Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression. Plos One. 10: e0135764. PMID 26270543 DOI: 10.1371/Journal.Pone.0135764  0.308
2015 Siepel FJ, Dalen I, Grüner R, Booij J, Brønnick KS, Buter TC, Aarsland D. Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26207978 DOI: 10.1002/Mds.26327  0.33
2015 Shalgunov V, van Wieringen JP, Janssen HM, Fransen PM, Dierckx RA, Michel MC, Booij J, Elsinga PH. Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers. Ejnmmi Research. 5: 119. PMID 26205538 DOI: 10.1186/S13550-015-0119-X  0.337
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/S11682-015-9419-Z  0.75
2015 Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review. Ejnmmi Research. 5: 12. PMID 25853018 DOI: 10.1186/S13550-015-0087-1  0.359
2015 Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MW, van den Brink W, Booij J. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. Psychopharmacology. 232: 2597-607. PMID 25757673 DOI: 10.1007/S00213-015-3891-4  0.524
2015 Bakker G, Vingerhoets WA, van Wieringen JP, de Bruin K, Eersels J, de Jong J, Chahid Y, Rutten BP, DuBois S, Watson M, Mogg AJ, Xiao H, Crabtree M, Collier DA, Felder CC, ... ... Booij J, et al. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 317-22. PMID 25593117 DOI: 10.2967/Jnumed.114.147488  0.341
2015 Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J. Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats. Journal of Psychopharmacology (Oxford, England). 29: 344-8. PMID 25586403 DOI: 10.1177/0269881114565380  0.486
2015 Gevonden MJ, Myin-Germeys I, van den Brink W, van Os J, Selten JP, Booij J. Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment. Psychological Medicine. 45: 1665-74. PMID 25482840 DOI: 10.1017/S0033291714002797  0.484
2015 Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/Npp.2014.301  0.76
2015 Bongers P, van de Giessen E, Roefs A, Nederkoorn C, Booij J, van den Brink W, Jansen A. Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 34: 677-85. PMID 25365413 DOI: 10.1037/Hea0000167  0.413
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z  0.706
2014 van Wieringen JP, Michel MC, Janssen HM, Janssen AG, Elsinga PH, Booij J. Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors. Ejnmmi Research. 4: 53. PMID 25977878 DOI: 10.1186/S13550-014-0053-3  0.357
2014 van Wieringen JP, de Bruin K, Janssen HM, Fransen PM, Janssen AG, van Doremalen PA, Michel MC, Elsinga PH, Booij J. Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors. International Journal of Molecular Imaging. 2014: 507012. PMID 25610643 DOI: 10.1155/2014/507012  0.363
2014 Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MW, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug and Alcohol Dependence. 145: 101-5. PMID 25454407 DOI: 10.1016/J.Drugalcdep.2014.09.783  0.403
2014 de Kwaasteniet BP, Pinto C, Ruhé EH, van Wingen GA, Booij J, Denys D. Striatal dopamine D2/3 receptor availability in treatment resistant depression. Plos One. 9: e113612. PMID 25411966 DOI: 10.1371/Journal.Pone.0113612  0.353
2014 Siepel FJ, Brønnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Grüner R, Aarsland D. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1802-8. PMID 25284687 DOI: 10.1002/Mds.26051  0.325
2014 Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Jama Psychiatry. 71: 1364-72. PMID 25271822 DOI: 10.1001/Jamapsychiatry.2014.1325  0.476
2014 Sharifi S, Nederveen AJ, Booij J, van Rootselaar AF. Neuroimaging essentials in essential tremor: a systematic review. Neuroimage. Clinical. 5: 217-31. PMID 25068111 DOI: 10.1016/J.Nicl.2014.05.003  0.309
2014 Hesse S, van de Giessen E, Zientek F, Petroff D, Winter K, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Darcourt J, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, ... ... Booij J, et al. Association of central serotonin transporter availability and body mass index in healthy Europeans. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1240-7. PMID 24976619 DOI: 10.1016/J.Euroneuro.2014.05.005  0.315
2014 Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, Raijmakers P, Foncke EM, van de Giessen E, Berendse HW, van den Heuvel OA. Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 904-11. PMID 24832846 DOI: 10.1002/Mds.25886  0.401
2014 Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, et al. Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1938-46. PMID 24806112 DOI: 10.1007/S00259-014-2785-8  0.405
2014 van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. Journal of Psychopharmacology (Oxford, England). 28: 866-73. PMID 24785761 DOI: 10.1177/0269881114531664  0.502
2014 Crunelle CL, van den Brink W, Dom G, Booij J. Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD. The British Journal of Psychiatry : the Journal of Mental Science. 204: 486-7. PMID 24676965 DOI: 10.1192/Bjp.Bp.113.132977  0.505
2014 Booij J, van Loon G, de Bruin K, Voorn P. Acute administration of haloperidol does not influence 123I-FP-CIT binding to the dopamine transporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 647-9. PMID 24604911 DOI: 10.2967/Jnumed.113.132340  0.403
2014 De Koning MB, Bloemen OJ, Van Duin ED, Booij J, Abel KM, De Haan L, Linszen DH, Van Amelsvoort TA. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis. Journal of Psychopharmacology (Oxford, England). 28: 553-560. PMID 24526133 DOI: 10.1177/0269881113519507  0.375
2014 Ruhé HG, Koster M, Booij J, van Herk M, Veltman DJ, Schene AH. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. Psychiatry Research. 221: 155-61. PMID 24406081 DOI: 10.1016/J.Pscychresns.2013.12.003  0.324
2014 van Wieringen JP, Shalgunov V, Janssen HM, Fransen PM, Janssen AG, Michel MC, Booij J, Elsinga PH. Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine Dâ‚‚/₃ receptors in their high-affinity state. Journal of Medicinal Chemistry. 57: 391-410. PMID 24325578 DOI: 10.1021/Jm401384W  0.343
2014 Knol RJ, de Bruin K, Opmeer B, Voorn P, Jonker AJ, van Eck-Smit BL, Booij J. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats. Nuclear Medicine and Biology. 41: 90-5. PMID 24267055 DOI: 10.1016/J.Nucmedbio.2013.10.003  0.387
2014 Suwijn SR, de Bruin K, de Bie RM, Booij J. The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease. Parkinsonism & Related Disorders. 20: S184-6. PMID 24262177 DOI: 10.1016/S1353-8020(13)70043-9  0.364
2014 Vriend C, Pattij T, van der Werf YD, Voorn P, Booij J, Rutten S, Berendse HW, van den Heuvel OA. Depression and impulse control disorders in Parkinson's disease: two sides of the same coin? Neuroscience and Biobehavioral Reviews. 38: 60-71. PMID 24239733 DOI: 10.1016/J.Neubiorev.2013.11.001  0.313
2014 Figee M, de Koning P, Klaassen S, Vulink N, Mantione M, van den Munckhof P, Schuurman R, van Wingen G, van Amelsvoort T, Booij J, Denys D. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder. Biological Psychiatry. 75: 647-52. PMID 23938318 DOI: 10.1016/J.Biopsych.2013.06.021  0.313
2013 Koopman KE, Booij J, Fliers E, Serlie MJ, la Fleur SE. Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region. Molecular Metabolism. 2: 417-22. PMID 24327957 DOI: 10.1016/J.Molmet.2013.07.006  0.326
2013 Suwijn SR, Berendse HW, Verschuur CV, Winogrodzka A, de Bie RM, Booij J. SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias. Ejnmmi Research. 3: 44. PMID 23738774 DOI: 10.1186/2191-219X-3-44  0.38
2013 Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1714-23. PMID 23731497 DOI: 10.1016/J.Euroneuro.2013.05.002  0.478
2013 van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug and Alcohol Dependence. 131: 198-203. PMID 23726981 DOI: 10.1016/J.Drugalcdep.2013.05.007  0.461
2013 Thomsen G, Knudsen GM, Jensen PS, Ziebell M, Holst KK, Asenbaum S, Booij J, Darcourt J, Dickson JC, Kapucu OL, Nobili F, Sabri O, Sera T, Tatsch K, Tossici-Bolt L, et al. No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. Ejnmmi Research. 3: 39. PMID 23688063 DOI: 10.1186/2191-219X-3-39  0.325
2013 Borgers AJ, Alkemade A, Van de Giessen EM, Drent ML, Booij J, Bisschop PH, Fliers E. Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus. Ejnmmi Research. 3: 34. PMID 23618227 DOI: 10.1186/2191-219X-3-34  0.399
2013 Schouw ML, Caan MW, Geurts HM, Schmand B, Booij J, Nederveen AJ, Reneman L. Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1491-502. PMID 23415394 DOI: 10.1016/J.Euroneuro.2013.01.005  0.807
2013 Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage. 72: 1-9. PMID 23296186 DOI: 10.1016/J.Neuroimage.2012.12.056  0.781
2013 Booij J, Reneman L, Alders M, Kuijpers TW. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. American Journal of Medical Genetics. Part A. 161: 102-7. PMID 23239620 DOI: 10.1002/Ajmg.A.35687  0.64
2013 Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, Ell P, Kapucu O, Kemp P, Svarer C, Varer C, Morbelli S, Pagani M, Sabri O, Tatsch K, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. European Journal of Nuclear Medicine and Molecular Imaging. 40: 565-73. PMID 23232506 DOI: 10.1007/S00259-012-2304-8  0.325
2013 van Wieringen JP, Booij J, Shalgunov V, Elsinga P, Michel MC. Agonist high- and low-affinity states of dopamine Dâ‚‚ receptors: methods of detection and clinical implications. Naunyn-Schmiedeberg's Archives of Pharmacology. 386: 135-54. PMID 23224422 DOI: 10.1007/S00210-012-0817-0  0.35
2013 Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Knudsen GM, Koulibaly PM, Nobili F, Pagani M, Sabri O, Vander Borght T, Van Laere K, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. European Journal of Nuclear Medicine and Molecular Imaging. 40: 213-27. PMID 23160999 DOI: 10.1007/S00259-012-2276-8  0.34
2013 Booij J, van de Giessen E, Hesse S, Sabri O. Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects. European Journal of Nuclear Medicine and Molecular Imaging. 40: 143-4. PMID 23093213 DOI: 10.1007/S00259-012-2267-9  0.359
2013 Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug and Alcohol Dependence. 129: 18-24. PMID 23026814 DOI: 10.1016/J.Drugalcdep.2012.09.006  0.449
2013 van de Giessen E, Hesse S, Caan MW, Zientek F, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Guignard R, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, Van Laere K, ... ... Booij J, et al. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage. 64: 61-7. PMID 22982354 DOI: 10.1016/J.Neuroimage.2012.09.011  0.368
2013 van de Giessen E, la Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity (2005). 37: 754-7. PMID 22868829 DOI: 10.1038/Ijo.2012.128  0.455
2013 Bloemen OJ, de Koning MB, Gleich T, Meijer J, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 126-32. PMID 22591910 DOI: 10.1016/J.Euroneuro.2012.04.015  0.36
2013 Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJ, de Bruin K, van den Brink W, Booij J. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction Biology. 18: 908-11. PMID 21955259 DOI: 10.1111/J.1369-1600.2011.00369.X  0.525
2013 Figee M, Vulink N, Van Wingen G, Booij J, Denys D. P.4.f.004 Deep brain stimulation in obsessive–compulsive disorder induces striatal dopamine release European Neuropsychopharmacology. 23: S533. DOI: 10.1016/S0924-977X(13)70846-0  0.333
2012 Booij J, van Amelsvoort T. Imaging as tool to investigate psychoses and antipsychotics. Handbook of Experimental Pharmacology. 299-337. PMID 23129337 DOI: 10.1007/978-3-642-25761-2_12  0.317
2012 Klomp A, den Hollander B, de Bruin K, Booij J, Reneman L. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One. 7: e47524. PMID 23115651 DOI: 10.1371/Journal.Pone.0047524  0.76
2012 Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, van den Brink W. Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain and Behavior. 2: 499-523. PMID 22950052 DOI: 10.1002/Brb3.65  0.474
2012 Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, Barber C, Carter J, Walker Z. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1063-70. PMID 22869921 DOI: 10.1136/Jnnp-2012-302577  0.327
2012 Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/Ajnr.A3217  0.711
2012 Koopman KE, la Fleur SE, Fliers E, Serlie MJ, Booij J. Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1087-90. PMID 22627000 DOI: 10.2967/Jnumed.111.102277  0.358
2012 van de Giessen E, Nimgaonkar VL, Watson AM, Kodavali C, Baas F, Tanck MW, de Win MM, van den Brink W, Booij J. Association tests of striatal DAT availability and SNPs that impact a novel splice variant in the DAT gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 839. PMID 22427685 DOI: 10.2967/Jnumed.111.100271  0.44
2012 Beukers RJ, Contarino MF, Speelman JD, Schuurman PR, Booij J, Tijssen MA. Deep Brain Stimulation of the Pallidum is Effective and Might Stabilize Striatal D(2) Receptor Binding in Myoclonus-Dystonia. Frontiers in Neurology. 3: 22. PMID 22363319 DOI: 10.3389/Fneur.2012.00022  0.366
2012 van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring, Md.). 20: 1738-40. PMID 22307070 DOI: 10.1038/Oby.2012.17  0.459
2012 Crunelle CL, de Wit TC, de Bruin K, Ramakers RM, van der Have F, Beekman FJ, van den Brink W, Booij J. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. Nuclear Medicine and Biology. 39: 640-4. PMID 22261145 DOI: 10.1016/J.Nucmedbio.2011.11.006  0.548
2012 Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, Nederveen AJ, Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 537-45. PMID 22209360 DOI: 10.1016/J.Euroneuro.2011.12.002  0.799
2012 Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology. 221: 329-39. PMID 22205158 DOI: 10.1007/S00213-011-2580-1  0.764
2012 Dickson JC, Tossici-Bolt L, Sera T, de Nijs R, Booij J, Bagnara MC, Seese A, Koulibaly PM, Akdemir UO, Jonsson C, Koole M, Raith M, Lonsdale MN, George J, Zito F, et al. Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. European Journal of Nuclear Medicine and Molecular Imaging. 39: 188-97. PMID 22089660 DOI: 10.1007/S00259-011-1884-Z  0.333
2012 Ruhé HG, Booij J, Veltman DJ, Michel MC, Schene AH. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. The Journal of Clinical Psychiatry. 73: 451-9. PMID 21903032 DOI: 10.4088/Jcp.10M06584  0.315
2012 van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 290-9. PMID 21889317 DOI: 10.1016/J.Euroneuro.2011.07.015  0.482
2012 Koning MBD, Bloemen OJN, Duin EDV, Booij J, Haan LD, Linszen DH, Amelsvoort TAMJV. 15:30 Startle Reactivityand Prepulse Inhibition In Subjects At Ultra High Risk For Psychosis: Correlation With Striatal D2/3 Receptor Binding Following Dopamine Depletion Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70297-9  0.363
2011 Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK. Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor. European Journal of Medicinal Chemistry. 46: 5728-35. PMID 22000209 DOI: 10.1016/J.Ejmech.2011.06.023  0.316
2011 Booij J, Berendse HW. Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway. Journal of the Neurological Sciences. 310: 40-3. PMID 21840542 DOI: 10.1016/J.Jns.2011.07.029  0.301
2011 Bloemen OJ, Gleich T, de Koning MB, da Silva Alvis F, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Hippocampal glutamate levels and striatal dopamine D(2/3) receptor occupancy in subjects at ultra high risk of psychosis. Biological Psychiatry. 70: e1-2; author reply e. PMID 21481842 DOI: 10.1016/J.Biopsych.2010.11.030  0.333
2011 Boot E, Booij J, Zinkstok JR, Baas F, Swillen A, Owen MJ, Murphy DG, Murphy KC, Linszen DH, Van Amelsvoort TA. COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome. Synapse (New York, N.Y.). 65: 967-70. PMID 21465565 DOI: 10.1002/Syn.20932  0.348
2011 van de Giessen E, Groot PF, Booij J, van den Brink W, Veltman DJ, Nederveen AJ. Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging. Ajnr. American Journal of Neuroradiology. 32: 903-7. PMID 21330391 DOI: 10.3174/ajnr.A2383  0.385
2011 Booij J, Boot E, van Eeden S, van Amelsvoort T. Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT. Clinical Nuclear Medicine. 36: 148-9. PMID 21220985 DOI: 10.1097/Rlu.0B013E318203Be54  0.317
2011 Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 205-10. PMID 21130610 DOI: 10.1016/J.Euroneuro.2010.11.001  0.518
2011 Burke SM, van de Giessen E, de Win M, Schilt T, van Herk M, van den Brink W, Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine. 41: 419-29. PMID 20367893 DOI: 10.1017/S0033291710000486  0.551
2010 Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging. American Journal of Medical Genetics. Part A. 152: 2937-8. PMID 20949509 DOI: 10.1002/Ajmg.A.33665  0.337
2010 Veltman DJ, Ruhé HG, Booij J. Investigating serotonergic function using positron emission tomography: overview and recent findings. Current Pharmaceutical Design. 16: 1979-89. PMID 20370665 DOI: 10.2174/138161210791293033  0.332
2010 van de Giessen E, Booij J. The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1507-11. PMID 20309682 DOI: 10.1007/S00259-010-1424-2  0.405
2010 Crunelle CL, Miller ML, Booij J, van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 69-79. PMID 19959340 DOI: 10.1016/J.Euroneuro.2009.11.001  0.455
2010 Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, Walker Z, NÃ¥gren K, Tatsch K, Darcourt J. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 37: 434-42. PMID 19838704 DOI: 10.1007/S00259-009-1265-Z  0.36
2010 Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, NÃ¥gren K, Nobili F, Walker Z, Van Laere K. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 37: 443-50. PMID 19838702 DOI: 10.1007/S00259-009-1267-X  0.341
2009 Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, NÃ¥gren K, Darcourt J, Tatsch K, Van Laere KJ. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 36: 2093-102. PMID 19838703 DOI: 10.1007/S00259-009-1266-Y  0.304
2009 Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J. Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addiction Biology. 14: 500-2. PMID 19650815 DOI: 10.1111/J.1369-1600.2009.00168.X  0.531
2009 Ruhé HG, Booij J, Reitsma JB, Schene AH. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. European Journal of Nuclear Medicine and Molecular Imaging. 36: 841-9. PMID 19183998 DOI: 10.1007/S00259-008-1057-X  0.347
2009 Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, Benamer HT, Kemp P, Burn D, Tolosa E, Kulisevsky J, Cunha L, Costa D, Booij J, Tatsch K, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 500-8. PMID 19117369 DOI: 10.1002/Mds.22108  0.303
2009 van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 45-52. PMID 19091889 DOI: 10.2967/Jnumed.108.053652  0.482
2009 Ruhé HG, Ooteman W, Booij J, Michel MC, Moeton M, Baas F, Schene AH. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder. Pharmacogenetics and Genomics. 19: 67-76. PMID 18987562 DOI: 10.1097/Fpc.0B013E32831A6A3A  0.304
2009 Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IH. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug and Alcohol Dependence. 99: 183-92. PMID 18823721 DOI: 10.1016/J.Drugalcdep.2008.07.012  0.486
2009 Beukers RJ, Booij J, Weisscher N, Zijlstra F, van Amelsvoort TA, Tijssen MA. Reduced striatal D2 receptor binding in myoclonus-dystonia. European Journal of Nuclear Medicine and Molecular Imaging. 36: 269-74. PMID 18719906 DOI: 10.1007/S00259-008-0924-9  0.377
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/Brain/Awn255  0.74
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/Bjp.Bp.106.035089  0.67
2008 Jongen C, de Bruin K, Beekman F, Booij J. SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1692-8. PMID 18425511 DOI: 10.1007/S00259-008-0795-0  0.388
2008 Visser I, Lavini C, Booij J, Reneman L, Majoie C, de Boer AG, Wekking EM, de Joode EA, van der Laan G, van Dijk FJ, Schene AH, Den Heeten GJ. Cerebral impairment in chronic solvent-induced encephalopathy. Annals of Neurology. 63: 572-80. PMID 18412121 DOI: 10.1002/Ana.21364  0.705
2008 Knol RJ, de Bruin K, de Jong J, van Eck-Smit BL, Booij J. In vitro and ex vivo storage phosphor imaging of short-living radioisotopes. Journal of Neuroscience Methods. 168: 341-57. PMID 18164072 DOI: 10.1016/J.Jneumeth.2007.10.028  0.312
2008 Zijlstra F, Booij J, van den Brink W, Franken IH. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 262-70. PMID 18077142 DOI: 10.1016/J.Euroneuro.2007.11.002  0.532
2008 Booij J, Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. European Journal of Nuclear Medicine and Molecular Imaging. 35: 424-38. PMID 17968545 DOI: 10.1007/S00259-007-0621-0  0.386
2008 Knol RJ, de Bruin K, van Eck-Smit BL, Booij J. No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats. European Journal of Nuclear Medicine and Molecular Imaging. 35: 598-604. PMID 17955237 DOI: 10.1007/S00259-007-0620-1  0.35
2008 Lindauer RJ, Booij J, Habraken JB, van Meijel EP, Uylings HB, Olff M, Carlier IV, den Heeten GJ, van Eck-Smit BL, Gersons BP. Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial. Psychological Medicine. 38: 543-54. PMID 17803835 DOI: 10.1017/S0033291707001432  0.535
2008 Boot E, Booij J, Zinkstok J, Abeling N, de Haan L, Baas F, Linszen D, van Amelsvoort T. Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1252-8. PMID 17653112 DOI: 10.1038/Sj.Npp.1301508  0.338
2008 Ruhe HG, Booij J, Schene AH. Season and gender modify in-vivo serotonin transporter binding in depressed patients and healthy controls Journal of Affective Disorders. 107. DOI: 10.1016/J.Jad.2007.12.056  0.328
2008 Ooteman W, Ruhe HG, Booij J, Michel MC, Schene AH. Serotonin transporter (SERT) polymorphism modifies the association between SERT occupancy and paroxetine treatment response: A [123I]β-CIT SPECT study Journal of Affective Disorders. 107. DOI: 10.1016/J.Jad.2007.12.029  0.303
2007 Booij J, Knol RJ. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease. Parkinsonism & Related Disorders. 13: S425-8. PMID 18267276 DOI: 10.1016/S1353-8020(08)70042-7  0.331
2007 Vastenhouw B, van der Have F, van der Linden AJ, von Oerthel L, Booij J, Burbach JP, Smidt MP, Beekman FJ. Movies of dopamine transporter occupancy with ultra-high resolution focusing pinhole SPECT. Molecular Psychiatry. 12: 984-7. PMID 17957236 DOI: 10.1038/Sj.Mp.4002028  0.384
2007 McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. The Lancet. Neurology. 6: 305-13. PMID 17362834 DOI: 10.1016/S1474-4422(07)70057-1  0.339
2007 de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/Sj.Npp.1301225  0.746
2006 Booij J, de Bruin K, Gunning WB. Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study. Nuclear Medicine and Biology. 33: 409-11. PMID 16631090 DOI: 10.1016/J.Nucmedbio.2005.12.007  0.721
2006 Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266  0.655
2006 Booij J, de Win MM. Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults. Nuclear Medicine and Biology. 33: 185-91. PMID 16546672 DOI: 10.1016/J.Nucmedbio.2005.10.005  0.371
2006 de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275  0.612
2006 Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515  0.761
2005 De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/Mpr.6  0.743
2005 Franken IH, Booij J, van den Brink W. The role of dopamine in human addiction: from reward to motivated attention. European Journal of Pharmacology. 526: 199-206. PMID 16256105 DOI: 10.1016/J.Ejphar.2005.09.025  0.521
2005 de Haan L, Booij J, Lavalye J, van Amelsvoort T, Linszen D. Subjective experiences during dopamine depletion. The American Journal of Psychiatry. 162: 1755. PMID 16135643 DOI: 10.1176/Appi.Ajp.162.9.1755  0.335
2005 de Haan L, Lavalaye J, Booij J, Linszen D. Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics. The American Journal of Psychiatry. 162: 1544-5. PMID 16055785 DOI: 10.1176/Appi.Ajp.162.8.1544  0.312
2005 Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB, Booij J. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Neuroimage. 26: 1150-8. PMID 15908232 DOI: 10.1016/J.Neuroimage.2005.03.034  0.388
2005 de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/Sj.Npp.1300683  0.756
2005 Winogrodzka A, Wagenaar RC, Booij J, Wolters EC. Rigidity and bradykinesia reduce interlimb coordination in Parkinsonian gait. Archives of Physical Medicine and Rehabilitation. 86: 183-9. PMID 15706541 DOI: 10.1016/J.Apmr.2004.09.010  0.318
2005 Stoffers D, Booij J, Bosscher L, Winogrodzka A, Wolters EC, Berendse HW. Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease. European Journal of Nuclear Medicine and Molecular Imaging. 32: 689-95. PMID 15682332 DOI: 10.1007/S00259-004-1733-4  0.342
2004 Lindauer RJ, Booij J, Habraken JB, Uylings HB, Olff M, Carlier IV, den Heeten GJ, van Eck-Smit BL, Gersons BP. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder. Biological Psychiatry. 56: 853-61. PMID 15576062 DOI: 10.1016/J.Biopsych.2004.08.003  0.525
2004 Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Annals of Neurology. 56: 173-81. PMID 15293269 DOI: 10.1002/Ana.20160  0.344
2004 de Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 290-6. PMID 15198464 DOI: 10.1177/070674370404900503  0.364
2004 de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 185-9. PMID 15056477 DOI: 10.1016/S0924-977X(03)00101-9  0.732
2004 de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/S00213-003-1723-4  0.743
2003 Booij J, de Bruin K, de Win MM, Lavini C, den Heeten GJ, Habraken JB. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible. Nuclear Medicine and Biology. 30: 643-9. PMID 12900290 DOI: 10.1016/S0969-8051(03)00046-5  0.643
2003 Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 294-8. PMID 12588911 DOI: 10.1136/jnnp.74.3.294  0.583
2003 de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. The American Journal of Psychiatry. 160: 303-9. PMID 12562577 DOI: 10.1176/Appi.Ajp.160.2.303  0.332
2002 Booij J, de Bruin K, Habraken JB, Voorn P. Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1221-4. PMID 12418461 DOI: 10.1007/S00259-002-0845-Y  0.417
2002 Zijlmans J, Booij J, Valk J, Lees A, Horstink M. Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1086-8. PMID 12360565 DOI: 10.1002/Mds.10203  0.31
2002 Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse (New York, N.Y.). 46: 199-205. PMID 12325046 DOI: 10.1002/Syn.10130  0.722
2002 Haddad PM, Strickland P, Anderson I, Deakin JFW, Dursun SM, Ratzenböck E, Reneman L, Booij J, Den Heeten GJ, Van Den Brink W. Effects of MDMA (ecstasy) use and abstention on serotonin neurons [1] (multiple letters) Lancet. 359: 1616-1618. PMID 12047988 DOI: 10.1016/S0140-6736(02)08490-8  0.654
2002 Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/S00213-001-0930-0  0.77
2002 Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 387-96. PMID 11850153 DOI: 10.1016/S0893-133X(01)00366-9  0.573
2001 Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/Hup.347  0.746
2001 Winogrodzka A, Wagenaar RC, Bergmans P, Vellinga A, Booij J, van Royen EA, van Emmerik RE, Stoof JC, Wolters EC. Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 1033-40. PMID 11748734 DOI: 10.1002/Mds.1205  0.597
2001 Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X  0.802
2001 Winogrodzka A, Bergmans P, Booij J, van Royen EA, Janssen AG, Wolters EC. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1011-9. PMID 11716136 DOI: 10.1007/s007020170019  0.539
2001 Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026 DOI: 10.1001/Archpsyc.58.10.901  0.735
2001 Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. 156: 53-7. PMID 11465633 DOI: 10.1007/S002130000679  0.679
2001 Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, Wolters EC. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Annals of Neurology. 50: 34-41. PMID 11456307 DOI: 10.1002/Ana.1049  0.346
2001 Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology. 155: 107-9. PMID 11374328 DOI: 10.1007/S002130000670  0.726
2001 Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. European Journal of Nuclear Medicine. 28: 266-72. PMID 11315592 DOI: 10.1007/S002590000460  0.409
2001 Booij J, Bergmans P, Winogrodzka A, Speelman JD, Wolters EC. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Synapse (New York, N.Y.). 39: 101-8. PMID 11180497 DOI: 10.1002/1098-2396(200102)39:2<101::Aid-Syn1>3.0.Co;2-1  0.371
2001 Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse (New York, N.Y.). 39: 193-200. PMID 11169768 DOI: 10.1002/1098-2396(20010301)39:3<193::Aid-Syn1000>3.0.Co;2-F  0.786
2001 Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research. 47: 59-67. PMID 11163545 DOI: 10.1016/S0920-9964(00)00023-2  0.716
2000 Benamer HTS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MHIM, Sips HJWA, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [(123) I]-FP-CIT SPECT imaging: The [(123) I]-FP-CIT study group. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 503-510. PMID 28470733 DOI: 10.1002/1531-8257(200005)15:3<503::Aid-Mds1013>3.0.Co;2-V  0.314
2000 Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. European Journal of Nuclear Medicine. 27: 867-9. PMID 10952500 DOI: 10.1007/S002590000279  0.71
2000 Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. Ajnr. American Journal of Neuroradiology. 21: 1001-7. PMID 10871002  0.699
2000 de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American Journal of Psychiatry. 157: 1019-20. PMID 10831489 DOI: 10.1176/Appi.Ajp.157.6.1019  0.343
2000 Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 503-10. PMID 10830416 DOI: 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V  0.527
2000 Lavalaye J, Knol RJ, de Bruin K, Reneman L, Janssen AG, Booij J. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication. European Journal of Nuclear Medicine. 27: 346-9. PMID 10774889 DOI: 10.1007/S002590050044  0.631
2000 Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746 DOI: 10.1007/S002130050057  0.63
2000 Lavalaye J, Linszen DH, Booij J. No change in striatal dopamine transporter density in antipsychotic-naive patients with schizophrenia assessed with 123I-FP-CIT SPECT Schizophrenia Research. 41: 252. DOI: 10.1016/S0920-9964(00)90935-6  0.35
2000 Haan Ld, Lavalaye J, Linszen D, Dingemans P, Booij J. Subjective experience and striatal dopamine D2 receptor occupancy in patients with recent-onset schizophrenia treated with olanzapine or risperidone Schizophrenia Research. 41: 26. DOI: 10.1016/S0920-9964(00)90358-X  0.341
1999 Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Research. 92: 33-44. PMID 10688158 DOI: 10.1016/S0925-4927(99)00032-3  0.703
1999 Reneman L, Booij J, Lavalaye J, De Bruin K, De Wolff FA, Koopmans RP, Stoof JC, Den Heeten GJ. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse (New York, N.Y.). 34: 77-80. PMID 10459174 DOI: 10.1002/(Sici)1098-2396(199910)34:1<77::Aid-Syn9>3.0.Co;2-Y  0.706
1999 Stoof JC, Winogrodzka A, van Muiswinkel FL, Wolters EC, Voorn P, Groenewegen HJ, Booij J, Drukarch B. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. European Journal of Pharmacology. 375: 75-86. PMID 10443566 DOI: 10.1016/S0014-2999(99)00260-5  0.38
1999 Habraken JB, Booij J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 40: 1091-7. PMID 10405125  0.543
1999 Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 40: 753-61. PMID 10319746  0.598
1999 Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. European Journal of Nuclear Medicine. 26: 171-82. PMID 9933352 DOI: 10.1007/s002590050374  0.558
1998 Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. European Journal of Nuclear Medicine. 25: 1666-9. PMID 9871099 DOI: 10.1007/S002590050346  0.719
1998 Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 1879-84. PMID 9829575  0.558
1998 Hulshof MC, Rehmann CJ, Booij J, van Royen EA, Bosch DA, González González D. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 48: 135-42. PMID 9783884 DOI: 10.1016/S0167-8140(98)00053-X  0.581
1998 Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 1143-8. PMID 9669384  0.555
1998 Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen EA, Stoof JC, Wolters EC. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. Journal of Neurology. 245: 14-20. PMID 9457623 DOI: 10.1007/S004150050168  0.631
1998 Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. European Journal of Nuclear Medicine. 25: 24-30. PMID 9396871 DOI: 10.1007/S002590050190  0.613
1997 Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse (New York, N.Y.). 27: 183-90. PMID 9329154 DOI: 10.1002/(Sici)1098-2396(199711)27:3<183::Aid-Syn4>3.0.Co;2-9  0.65
1997 Tissingh G, Bergmans P, Booij J, Winogrodzka A, Stoof JC, Wolters EC, Van Royen EA. [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls. European Journal of Nuclear Medicine. 24: 1171-4. PMID 9283113 DOI: 10.1007/Bf01254252  0.619
1997 Tissingh G, Bergmans P, Winogrodzka A, Stoof JC, Wolters EC, Booij J, Van Royen EA. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 1271-2. PMID 9255164  0.532
1997 Horstink CA, Praamstra P, Horstink MW, Berger HJ, Booij J, Van Royen EA. Low striatal D2 receptor binding as assessed by [123I]IBZM SPECT in patients with writer's cramp. Journal of Neurology, Neurosurgery, and Psychiatry. 62: 672-3. PMID 9219768  0.534
1997 Booij J, Korn P, Linszen DH, van Royen EA. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine. 24: 674-7. PMID 9169577 DOI: 10.1007/Bf00841408  0.584
1997 Claus JJ, Dubois EA, Booij J, Habraken J, de Munck JC, van Herk M, Verbeeten B, van Royen EA. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography. European Journal of Nuclear Medicine. 24: 602-8. PMID 9169565 DOI: 10.1007/s002590050093  0.56
1997 Tissingh G, Booij J, Winogrodzka A, van Royen EA, Wolters EC. IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism. Journal of Neural Transmission. Supplementum. 50: 31-7. PMID 9120422 DOI: 10.1007/978-3-7091-6842-4_4  0.628
1997 Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 62: 133-40. PMID 9048712  0.585
1997 Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. European Journal of Nuclear Medicine. 24: 68-71. PMID 9044880 DOI: 10.1007/Bf01728311  0.627
1996 Rijks LJ, Booij J, Doornbos T, Boer GJ, Ronken E, de Bruin K, Vermeulen RJ, Janssen AG, Van Royen EA. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands. Synapse (New York, N.Y.). 23: 201-7. PMID 8807748 DOI: 10.1002/(Sici)1098-2396(199607)23:3<201::Aid-Syn9>3.0.Co;2-C  0.614
1995 Vermeulen RJ, Wolters EC, Tissingh G, Booij J, Janssen AG, Habraken J, Sokole-Busemann E, Stoof JC, Van Royen EA. Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease. Nuclear Medicine and Biology. 22: 985-91. PMID 8998476 DOI: 10.1016/0969-8051(95)02020-9  0.567
1995 Booij J, van Royen EA. [Progressive supranuclear paralysis; a late diagnosis]. Nederlands Tijdschrift Voor Geneeskunde. 139: 1998-9. PMID 7477545  0.445
1992 Stoof JC, Booij J, Drukarch B, Wolters EC. The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way. European Journal of Pharmacology. 213: 439-43. PMID 1618282 DOI: 10.1016/0014-2999(92)90634-G  0.306
Show low-probability matches.